Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lifu Ma is active.

Publication


Featured researches published by Lifu Ma.


Organic and Biomolecular Chemistry | 2007

A highly effective one-pot synthesis of quinolines from o-nitroarylcarbaldehydes.

An-Hu Li; Eilaf Ahmed; Xin Chen; Matthew Cox; Andrew P. Crew; Hanqing Dong; Meizhong Jin; Lifu Ma; Bijoy Panicker; Kam W. Siu; Arno G. Steinig; Kathryn M. Stolz; Paula A. R. Tavares; Brian Volk; Qinghua Weng; Doug Werner; Mark J. Mulvihill

A highly effective one-pot Friedländer quinoline synthesis using inexpensive reagents has been developed. o-Nitroarylcarbaldehydes were reduced to o-aminoarylcarbaldehydes with iron in the presence of catalytic HCl (aq.) and subsequently condensed in situ with aldehydes or ketones to form mono- or di-substituted quinolines in high yields (66-100%).


Bioorganic & Medicinal Chemistry Letters | 2013

Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: Optimization of kinase selectivity and pharmacokinetics.

Keith R. Hornberger; Xin Chen; Andrew P. Crew; Andrew Kleinberg; Lifu Ma; Mark J. Mulvihill; Jing Wang; Victoria L. Wilde; Mark Albertella; Mark Bittner; Andrew Cooke; Salam Kadhim; Jennifer Kahler; Paul Maresca; Earl May; Peter Meyn; Darlene Romashko; Brianna Tokar; Roy Turton

The kinase selectivity and pharmacokinetic optimization of a series of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1 is described. The intersection of insights from molecular modeling, computational prediction of metabolic sites, and in vitro metabolite identification studies resulted in a simple and unique solution to both of these problems. These efforts culminated in the discovery of compound 13a, a potent, relatively selective inhibitor of TAK1 with good pharmacokinetic properties in mice, which was active in an in vivo model of ovarian cancer.


Archive | 2005

Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds

Saleh Ahmed; Oscar Barba; Jason Bloxham; Graham Dawson; William Gattrell; John Kitchin; Neil Anthony Pegg; Imaad Saba; Shazia Sadiq; Smith Colin Peter Sambrook; Don Smyth; Arno G. Steinig; Robin Wilkes; Kenneth Foreman; Qinghua Felix Weng; Kathryn M. Stolz; Paula A. R. Tavares; Bijoy Panicker; An-Hu Li; Hanqing Dong; Lifu Ma; Matthew Cox


Archive | 2011

7-AMINOFUROPYRIDINE DERIVATIVES

Keith R. Hornberger; Dan M. Berger; Xin Chen; Andrew P. Crew; Hanqing Dong; Andrew Kleinberg; An-Hu Li; Lifu Ma; Mark J. Mulvihill; Bijoy Panicker; Kam W. Siu; Arno G. Steinig; James G. Tarrant; Jing Wang; Qinghua Weng; Rajaram Sangem; Ramesh C. Gupta


Archive | 2014

Achiral Preparative Supercritical Fluid Chromatography

Vivi Lazarescu; Mark J. Mulvihill; Lifu Ma


Lc Gc North America | 2011

A Generic Workflow for Achiral SFC Purification of Complex Pharmaceutical Mixtures

Vivi Lazarescu; Mark J. Mulvihill; Lifu Ma


Archive | 2009

Case Studies on Compound-Specific Achiral SFC Purification

Vivi Lazarescu; Mark J. Mulvihill; Lifu Ma


Archive | 2005

Substituted pyrrolo[2.3-B]pyridines

Saleh Ahmed; Oscar Barba; Jason Bloxham; Graham Dawson; William Gattrell; John Kitchin; Neil Anthony Pegg; Imaad Saba; Shazia Sadiq; Colin Peter Sambrook Smith; Don Smyth; Amo G. Steinig; Robin Wilkes; Bijoy Panicker; Paula A. R. Tavares; Matthew Cox; An-Hu Li; Hanqing Dong; Lifu Ma; Kenneth Foreman; Qinghua Weng; Kathryn M. Stolz


Archive | 2012

Proton nmr spectroscopy for biochemical screening

Yingjie Li; Lifu Ma; Mark J. Mulvihill


Archive | 2012

Spectroscopie rmn du proton pour criblage biochimique

Yingjie Li; Lifu Ma; Mark J. Mulvihill

Collaboration


Dive into the Lifu Ma's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge